These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30412705)

  • 1. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease.
    Li B; Zhu X; Ward CM; Starlard-Davenport A; Takezaki M; Berry A; Ward A; Wilder C; Neunert C; Kutlar A; Pace BS
    Exp Hematol; 2019 Feb; 70():85-96.e5. PubMed ID: 30412705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors.
    Palani CD; Zhu X; Alagar M; Attucks OC; Pace BS
    Blood Cells Mol Dis; 2024 Jan; 104():102792. PubMed ID: 37633023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway.
    Pullarkat V; Meng Z; Tahara SM; Johnson CS; Kalra VK
    Hemoglobin; 2014; 38(3):188-95. PubMed ID: 24670032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
    Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
    Zein S; Li W; Ramakrishnan V; Lou TF; Sivanand S; Mackie A; Pace B
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1385-94. PubMed ID: 20975082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia.
    Cyrus C; Vatte C; Al-Nafie A; Chathoth S; Akhtar MS; Darwish M; Almohazey D; AlDubayan SH; Steinberg MH; Al-Ali A
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295630
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells.
    Li H; Lin R; Li H; Ou R; Wang K; Lin J; Li C
    Hematology; 2022 Dec; 27(1):1152-1162. PubMed ID: 36178486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
    Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
    Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma modulates fetal hemoglobin synthesis in sickle cell anemia and thalassemia.
    Miller BA; Olivieri N; Hope SM; Faller DV; Perrine SP
    J Interferon Res; 1990 Aug; 10(4):357-66. PubMed ID: 1700029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugate prodrug AN-233 induces fetal hemoglobin expression in sickle erythroid progenitors and β-YAC transgenic mice.
    Oseghale AR; Zhu X; Li B; Peterson KR; Nudelman A; Rephaeli A; Xu H; Pace BS
    Blood Cells Mol Dis; 2019 Nov; 79():102345. PubMed ID: 31351219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients.
    Fibach E; Bianchi N; Borgatti M; Zuccato C; Finotti A; Lampronti I; Prus E; Mischiati C; Gambari R
    Eur J Haematol; 2006 Nov; 77(5):437-41. PubMed ID: 16939628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomethylfumarate induces γ-globin expression and fetal hemoglobin production in cultured human retinal pigment epithelial (RPE) and erythroid cells, and in intact retina.
    Promsote W; Makala L; Li B; Smith SB; Singh N; Ganapathy V; Pace BS; Martin PM
    Invest Ophthalmol Vis Sci; 2014 May; 55(8):5382-93. PubMed ID: 24825111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.
    Sangokoya C; Telen MJ; Chi JT
    Blood; 2010 Nov; 116(20):4338-48. PubMed ID: 20709907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of aberrantly expressed lncRNAs and miRNAs with associated co-expression and ceRNA networks in β-thalassemia and hereditary persistence of fetal hemoglobin.
    Lai K; Jia S; Yu S; Luo J; He Y
    Oncotarget; 2017 Jul; 8(30):49931-49943. PubMed ID: 28624809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway.
    Macari ER; Lowrey CH
    Blood; 2011 Jun; 117(22):5987-97. PubMed ID: 21464371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients.
    Kargutkar N; Sawant-Mulay M; Hariharan P; Chandrakala S; Nadkarni A
    Sci Rep; 2023 Jan; 13(1):369. PubMed ID: 36611033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors.
    Baliga BS; Pace BS; Chen HH; Shah AK; Yang YM
    Am J Hematol; 2000 Nov; 65(3):227-33. PubMed ID: 11074540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
    Renneville A; Van Galen P; Canver MC; McConkey M; Krill-Burger JM; Dorfman DM; Holson EB; Bernstein BE; Orkin SH; Bauer DE; Ebert BL
    Blood; 2015 Oct; 126(16):1930-9. PubMed ID: 26320100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
    Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
    Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.